Acro Biomedical Co (ACBM) Stock Statistics & Valuation Metrics

Acro Biomedical Co has a market cap or net worth of $42.03K. The enterprise value is ―.

Acro Biomedical Co has 60,042,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Acro Biomedical Co’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 15.74%.

The current PE Ratio of Acro Biomedical Co is ―. Acro Biomedical Co’s PEG ratio is 0.01.

In the last 12 months, Acro Biomedical Co had revenue of 0.00 and earned -42.30K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -162.18K and capital expenditures 4.00, giving a free cash flow of -162.18K billion.

Acro Biomedical Co pays an annual dividend of ―, resulting in a dividend yield of ―

Acro Biomedical Co upcoming earnings date is ―, ―.

Acro Biomedical Co as a current ratio of 0.02, with Debt / Equity ratio of -80.41%

In the past 12 months, Acro Biomedical Co has paid 0.00 in taxes.

Acro Biomedical Co EV to EBITDA ratio is -2.28, with an EV/FCF ratio of -2.36.

Acro Biomedical Co has $26.00 in cash and marketable securities with $255.30K in debt, giving a net cash position of -$255.28K billion.

Gross margin is 17.78%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Acro Biomedical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―